5ANDREAS M, UI.RICH S, HANS-JURGEN H, et al. Prospects of remission in medullarythyroid carcinoma according to basal calcitonin levcl[J]. The J Endocrinol Metabol, 2005,90 (4) :2029- 2034.
6SINGH B, SHAHA AR, TRIVEI)I H, et al. coexistent Hashimoto's with papillary thyroid carcinoma: impact on prensentation,management, andourcome[J]. Surgery, 1999, 126(6):1070 -1077.
7Andreas M,Ulrich S,Hans-Jurgen H,et al.Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level[J].J Endocrinol Metabol,2005,90(4):2029-2034.
8Singh B,Shaha AR,Trivedi H,et al.Coexistent Hashimoto's with papillary thyroid carcinoma impact on presentation,management,and outcome[J].Surgery,1999,126(6):1070-1076; discussion 1076-1077.
9Randolph GW,Maniar D.Medullary carcinoma of the thyroid[J].Cancer Control,2000,7(3):253-260.
10Hofstra RM,Landsvater RM,Ceccherini I,et al.A mutation in the RET protooncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary carcinoma[J].Nature 1994;367(6461):375-376.
